Production, Radiochemical Separation and Radiolabeling of Gold Nanoparticle Bioconjugates with 211At for Targeted Alpha Therapy

被引：0
|
作者：
Ghosh, S. [1 ,2 ]
Banerjee, D. [1 ,3 ]
Chakravarty, R. [1 ,2 ]
机构：
[1] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India
[2] Bhabha Atom Res Ctr, Radiopharmaceut Div, Mumbai, Maharashtra, India
[3] BARC, Variable Energy Cyclotron Ctr, Radiochem Div, Kolkata, India
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-280
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [1] Gold nanoparticle bioconjugates labelled with 211At for targeted alpha therapy
    Dziawer, L.
    Kozminski, P.
    Meczynska-Wielgosz, S.
    Pruszynski, M.
    Lyczko, M.
    Was, B.
    Celichowski, G.
    Grobelny, J.
    Jastrzebski, J.
    Bilewicz, A.
    RSC ADVANCES, 2017, 7 (65): : 41024 - 41032
  • [2] Bioconjugates of gold nanoparticles with trastuzumab labelled with 211At for internal alpha therapy
    Bilewicz, Aleksander
    Dziawer, Lucja
    Kozminski, Przemyslaw
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S66 - S66
  • [3] 211At on gold nanoparticles for targeted radionuclide therapy application
    Tanudji, Jeffrey
    Kasai, Hideaki
    Okada, Michio
    Ogawa, Tetsuo
    Aspera, Susan M.
    Nakanishi, Hiroshi
    PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2024, 26 (17) : 12915 - 12927
  • [4] Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy
    Ghosh, Sanchita
    Banerjee, Debashis
    Guleria, Apurav
    Chakravarty, Rubel
    NUCLEAR MEDICINE AND BIOLOGY, 2024, 138
  • [5] Development of a preclinical 211Rn/211At generator system for targeted alpha therapy research with 211At
    Crawford, Jason R.
    Yang, Hua
    Kunz, Peter
    Wilbur, D. Scott
    Schaffer, Paul
    Ruth, Thomas J.
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 48 : 31 - 35
  • [6] Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy
    Guerard, Francois
    Gestin, Jean-Francois
    Brechbiel, Martin W.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (01) : 1 - 20
  • [7] Gold Nanoparticle-Substance P(5-11) Conjugate as a Carrier for 211At in Alpha Particle Therapy
    Bilewicz, A.
    Janiszewska
    Kozminski, P.
    Lyczko, M.
    Pruszynski, M.
    Jastrzebski, J.
    Choinski, J.
    Stolarz, A.
    Trzcinska, A.
    Szkliniarz, K.
    Zipper, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S245 - S245
  • [8] 211At radiolabeled APBA-FAPI for enhanced targeted-alpha therapy of glioma
    Ye, Tianzhen
    Yu, Yuying
    Qu, Guofeng
    Ma, Huan
    Shi, Shilong
    Ji, Jiujian
    Lyu, Jie
    Yang, Yuanyou
    Liu, Ning
    Li, Feize
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 279
  • [9] Development of meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma
    Batra, Vandana
    Ranieri, Pietro
    Makvandi, Mehran
    Tsang, Matthew
    Hou, Catherine
    Li, Yimei
    Vaidyanathan, Ganesan
    Pryma, Daniel A.
    Maris, John M.
    CANCER RESEARCH, 2015, 75
  • [10] Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
    Batra, Vandana
    Samanta, Minu
    Makvandi, Mehran
    Groff, David
    Martorano, Paul
    Elias, Jimmy
    Ranieri, Pietro
    Tsang, Matthew
    Hou, Catherine
    Li, Yimei
    Pawel, Bruce
    Martinez, Daniel
    Vaidyanathan, Ganesan
    Carlin, Sean
    Pryma, Daniel A.
    Maris, John M.
    CLINICAL CANCER RESEARCH, 2022, 28 (18) : 4146 - 4157
12345